SCHEMBL5152146

SCHEMBL5152146

CC(C)Oc1cc([N+](=O)[O-])ccc1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.57
SMN1; SMN2 Q16637 4/20 0.51
ALDH1A1 P00352 3/20 0.51
GPR35 Q9HC97 2/20 0.51
TP53 P04637 1/20 0.51
HPGD P15428 1/20 0.51
TSHR P16473 1/20 0.51
MAPK1 P28482 1/20 0.51
GAA P10253 1/20 0.50
THRB P10828 1/20 0.50
HTT P42858 5/20 0.47
ERN1 O75460 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
LMNA P02545 2/20 0.44
MEN1 O00255 2/20 0.44
NPC1 O15118 2/20 0.44
MAPT P10636 2/20 0.44
KMT2A Q03164 2/20 0.44
PKM P14618 2/20 0.44
HSP90AA1 P07900 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2039588 0.87 CYP19A1 (0.54) CYP19A1SMN1; SMN2ALDH1A1GPR35TP53
SCHEMBL8128575 0.84 SMN1; SMN2 (0.46) CYP19A1SMN1; SMN2ALDH1A1GPR35TP53
SCHEMBL11835883 0.84 CYP19A1 (0.61) CYP19A1SMN1; SMN2ALDH1A1TSHRHTT
SCHEMBL31081103 0.83 HTT (0.60) CYP19A1SMN1; SMN2ALDH1A1HPGDMAPK1
SCHEMBL22954121 0.83 ALDH1A1 (0.51) SMN1; SMN2ALDH1A1GPR35TP53HPGD
SCHEMBL3820703 0.83 HTT (0.60) CYP19A1SMN1; SMN2ALDH1A1HPGDMAPK1
SCHEMBL9699062 0.81 CYP19A1 (0.58) CYP19A1SMN1; SMN2ALDH1A1TSHRHTT
SCHEMBL3295088 0.81 HTT (0.67) CYP19A1SMN1; SMN2ALDH1A1TSHRGAA
SCHEMBL221924 0.81 HTT (0.66) SMN1; SMN2ALDH1A1GPR35TP53HPGD
SCHEMBL31493924 0.81 HTT (0.66) SMN1; SMN2ALDH1A1GPR35TP53HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007071840-A2 COMPOUNDS BASED ON FOUR AROMATIC RINGS, PREPARATION AND USES THEREOF CEREP (FR) 2007-06-28 WO disclosed
EP-1135360-B1 NOVEL 3-ALKOXYBENZYLAMINE DERIVATIVES AND THEIR USE AS MEDICINES FOR TREATING SCHIZOPHRENIA PF MEDICAMENT (FR) 2004-03-31 EP disclosed
US-6350913-B1 AROMATIC AMINE COMPOUNDS PIERRE FABRE MEDICAMENT (FR) 2002-02-26 US disclosed
EP-1135360-A1 NOVEL 3-ALKOXYBENZYLAMINE DERIVATIVES AND THEIR USE AS MEDICINES FOR TREATING SCHIZOPHRENIA PIERRE FABRE MEDICAMENT (FR) 2001-09-26 EP disclosed
WO-2000032557-A1 NOVEL 3-ALKOXYBENZYLAMINE DERIVATIVES AND THEIR USE AS MEDICINES FOR TREATING SCHIZOPHRENIA PIERRE FABRE MEDICAMENT (FR) 2000-06-08 WO disclosed